{
    "title": "AstraZeneca gets much-needed boost from successful trials of new cancer drugs in the aftermath of Pfizer's failed takeover bid",
    "url": "https://www.dailymail.co.uk/money/markets/article-2645510/AstraZeneca-gets-needed-boost-successful-trials-new-cancer-drugs-aftermath-Pfizers-failed-takeover-bid.html",
    "date": "2014-06-01",
    "keywords": [
        "cancer",
        "pfizer",
        "soriot",
        "pipeline",
        "takeover",
        "bid",
        "boost",
        "astrazeneca",
        "cent",
        "johansson",
        "executive",
        "decision",
        "growth",
        "aftermath",
        "duncan",
        "mail",
        "gmt",
        "june",
        "email",
        "view",
        "target",
        "treatment",
        "hope",
        "battle",
        "lung",
        "casesand",
        "study",
        "combination",
        "length",
        "time",
        "disease",
        "value",
        "chairman",
        "meeting",
        "society",
        "oncology",
        "support",
        "astra",
        "leif",
        "part",
        "defence",
        "strategy",
        "life",
        "science",
        "park",
        "shot",
        "arm",
        "tech",
        "fall",
        "friday",
        "pressure",
        "market",
        "guarantee",
        "blackrock",
        "investor",
        "board",
        "coolingoff",
        "period",
        "share",
        "price",
        "incentive",
        "programme",
        "delivery"
    ],
    "category": [
        "money",
        "markets"
    ]
}